Health
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic – The Wall Street Journal
CEO Albert Bourla says company will use gene-based technology learned by working with Germany’s BioNTech to tackle other diseases
Pfizer Inc. aims to expand its vaccine business by becoming a leader in the new gene-based technology behind its successful Covid-19 shots.
Pfizer will develop new shots using the technology, called mRNA, to target other viruses and pathogens beyond the coronavirus, Chief Executive Albert Bourla said in an interview. He said the companys scientists and engineers gained a decades worth of experience in the past year working on the Covid-19 vaccine with Germanys BioNTech SE , and is ready to pursue…
-
Business23 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General23 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General7 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General22 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting